Gene Dosage Decoded: New Review Maps Path to Precision Therapy for CMT1A
A new narrative review maps the genetic architecture, regulatory landscape and emerging precision therapies for Charcot-Marie-Tooth disease type 1A.
A new narrative review maps the genetic architecture, regulatory landscape and emerging precision therapies for Charcot-Marie-Tooth disease type 1A.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.